Published in Therap Adv Gastroenterol on April 26, 2017
A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency. N Engl J Med (2015) 2.77
ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. Physiol Rev (2005) 2.76
Role of lysosomal acid lipase in the metabolism of plasma low density lipoprotein. Observations in cultured fibroblasts from a patient with cholesteryl ester storage disease. J Biol Chem (1975) 2.55
Lovastatin therapy for cholesterol ester storage disease in two sisters. J Pediatr (1991) 2.41
SREBPs: metabolic integrators in physiology and metabolism. Trends Endocrinol Metab (2011) 2.29
Receptor-dependent hydrolysis of cholesteryl esters contained in plasma low density lipoprotein. Proc Natl Acad Sci U S A (1975) 1.99
Generalized xanthomatosis with calcified adrenals. AMA J Dis Child (1956) 1.98
Clinical effect and safety profile of recombinant human lysosomal acid lipase in patients with cholesteryl ester storage disease. Hepatology (2013) 1.78
Long-term metabolic, endocrine, and neuropsychological outcome of hematopoietic cell transplantation for Wolman disease. Bone Marrow Transplant (2008) 1.71
Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease. J Hepatol (2013) 1.60
Enzyme replacement therapy for lysosomal diseases: lessons from 20 years of experience and remaining challenges. Annu Rev Genomics Hum Genet (2012) 1.37
WOLMAN'S DISEASE: THREE NEW PATIENTS WITH A RECENTLY DESCRIBED LIPIDOSIS. Pediatrics (1965) 1.28
Wolman's disease. A rare lipidosis with adrenal calcification. Arch Dis Child (1969) 1.21
Plasma lipids and lipoproteins of a patient with cholesteryl ester storage disease. J Inherit Metab Dis (1985) 1.12
Prevalence of cholesteryl ester storage disease. Arterioscler Thromb Vasc Biol (2007) 1.11
Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity. Genomics (1996) 1.10
Liver transplantation for cholesteryl ester storage disease. J Pediatr Gastroenterol Nutr (1991) 1.08
Characterization of lysosomal acid lipase by site-directed mutagenesis and heterologous expression. J Biol Chem (1995) 1.07
Lysosomal acid lipase deficiency--an under-recognized cause of dyslipidaemia and liver dysfunction. Atherosclerosis (2014) 1.07
Frequency of the cholesteryl ester storage disease common LIPA E8SJM mutation (c.894G>A) in various racial and ethnic groups. Hepatology (2013) 1.06
Sebelipase alfa over 52 weeks reduces serum transaminases, liver volume and improves serum lipids in patients with lysosomal acid lipase deficiency. J Hepatol (2014) 1.05
Mutations at the lysosomal acid cholesteryl ester hydrolase gene locus in Wolman disease. Proc Natl Acad Sci U S A (1994) 1.04
Cellular cholesterol substrate pools for adenosine-triphosphate cassette transporter A1-dependent high-density lipoprotein formation. Curr Opin Lipidol (2008) 1.04
Exome sequencing and directed clinical phenotyping diagnose cholesterol ester storage disease presenting as autosomal recessive hypercholesterolemia. Arterioscler Thromb Vasc Biol (2013) 1.03
Treatment of dyslipidemia with lovastatin and ezetimibe in an adolescent with cholesterol ester storage disease. Lipids Health Dis (2005) 1.03
Subclinical course of cholesteryl ester storage disease in an adult with hypercholesterolemia, accelerated atherosclerosis, and liver cancer. J Hepatol (2000) 1.00
Distinctive histopathological features that support a diagnosis of cholesterol ester storage disease in liver biopsy specimens. Histopathology (2012) 0.98
Use of simvastatin plus cholestyramine in the treatment of lysosomal acid lipase deficiency. J Pediatr (1991) 0.94
Successful treatment of Wolman disease by unrelated umbilical cord blood transplantation. Eur J Pediatr (2006) 0.94
A novel variant of lysosomal acid lipase in cholesteryl ester storage disease associated with mild phenotype and improvement on lovastatin. J Hepatol (1997) 0.94
Lysosomal acid lipase A and the hypercholesterolaemic phenotype. Curr Opin Lipidol (2013) 0.92
Clinical Features of Lysosomal Acid Lipase Deficiency. J Pediatr Gastroenterol Nutr (2015) 0.92
Wolman's disease: a review of treatment with bone marrow transplantation and considerations for the future. Bone Marrow Transplant (1992) 0.88
Lysosomal acid lipase deficiency impairs regulation of ABCA1 gene and formation of high density lipoproteins in cholesteryl ester storage disease. J Biol Chem (2011) 0.88
Cholesteryl ester storage disease: complex molecular effects of chronic lovastatin therapy. J Lipid Res (1992) 0.88
Genetic lipid storage disease with lysosomal acid lipase deficiency in rats. Lab Anim Sci (1990) 0.88
Lysosomal lipase deficiency: molecular characterization of eleven patients with Wolman or cholesteryl ester storage disease. Mol Genet Metab (2011) 0.87
Cholesteryl ester storage disease: protean presentations of lysosomal acid lipase deficiency. J Pediatr Gastroenterol Nutr (2013) 0.87
Pathological evidence of Wolman's disease following hematopoietic stem cell transplantation despite correction of lysosomal acid lipase activity. Bone Marrow Transplant (2009) 0.86
Accumulated lipids, aberrant fatty acid composition and defective cholesterol ester hydrolase activity in cholesterol ester storage disease. Ann Clin Biochem (2000) 0.85
Orthotopic liver transplantation for cholesteryl ester storage disease. J Clin Gastroenterol (1991) 0.84
Long-term administration of the HMG-CoA reductase inhibitor lovastatin in two patients with cholesteryl ester storage disease. Int J Clin Pharmacol Ther (2001) 0.84
Unfavorable outcome of hematopoietic stem cell transplantation in two siblings with Wolman disease due to graft failure and hepatic complications. Mol Genet Metab (2013) 0.84
Treatment and liver transplantation for cholesterol ester storage disease. J Pediatr (1995) 0.83
State of the art review. Bone marrow transplantation treatment for storage diseases. Keystone. January 23, 1992. Bone Marrow Transplant (1992) 0.83
Long-term treatment of a homozygous cholesteryl ester storage disease with combined cholestyramine and lovastatin. J Inherit Metab Dis (1992) 0.82
Asymptomatic cholesteryl ester storage disease in an adult controlled with simvastatin. Ann Clin Biochem (1997) 0.81
An update on laboratory diagnosis of liver inherited diseases. Biomed Res Int (2013) 0.80
End-stage renal disease in a patient with cholesteryl ester storage disease following successful liver transplantation and cyclosporine immunosuppression. J Pediatr Gastroenterol Nutr (1995) 0.79
Enaminones 11. An examination of some ethyl ester enaminone derivatives as anticonvulsant agents. Bioorg Med Chem (2013) 0.79
A practical fluorometric assay method to measure lysosomal acid lipase activity in dried blood spots for the screening of cholesteryl ester storage disease and Wolman disease. Mol Genet Metab (2013) 0.78
Treatment of cholesteryl ester storage disease with combined cholestyramine and lovastatin. Ann N Y Acad Sci (1991) 0.78
Identification and metabolic profiling of patients with lysosomal acid lipase deficiency. J Clin Lipidol (2015) 0.77
[7 years' experience with hepatic transplantation in children]. Cir Pediatr (1993) 0.76
Sebelipase Alfa: First Global Approval. Drugs (2015) 0.76
Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in cholesteryl ester storage disease. Clin Chem (1995) 0.76